Protein Kinases and Their Inhibitors
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Bioorganic Chemistry".
Deadline for manuscript submissions: closed (28 February 2023) | Viewed by 4594
Special Issue Editors
Interests: medicinal chemistry; autophagy; epigenetics; protein kinase inhibitors; breast cancer; Parkinson’s disease; drug repurposing
Interests: medicinal chemistry; autophagy; neurodegenerative disease; cancer; drug repurposing
Special Issue Information
Dear Colleagues,
Protein kinases (PKs) catalyze the transfer of the γ‑phosphate group of ATP onto a target substrate. A sequence of such phosphorylation events regulates numerous cellular activities, such as proliferation, survival, apoptosis, metabolism, transcription and differentiation. Owing to overexpression and genetic alterations such as mutations and translocations, the dysregulation of protein kinase activity is involved in the pathogenesis of many diseases including autoimmune, cardiovascular, neurodegenerative and inflammatory diseases, as well as a number of malignancies. Accordingly, protein kinases have become one of the most important drug targets over the past two decades. Although substantial progress has been made in the development and discovery of small-molecule protein kinase inhibitors since the FDA approval of imatinib in 2001, this field remains in its early stages. Therefore, we believe that the discovery and optimization of novel small-molecule protein kinase inhibitors will provide more information and experience to related researchers from both the pharmaceutical field and academia.
In this context, it is a great pleasure to invite you to contribute to this thematic Special Issue of Molecules entitled “Protein Kinases and Their Inhibitors”, which will cover the latest research trends and applications in the field. Submissions of reviews and original research papers are highly welcome. Topics of interest include, but are not limited to, the following:
- Design and discovery of novel small-molecule protein kinase inhibitors for disease treatment;
- Drug repositioning of protein kinase inhibitors.
Dr. Lan Zhang
Dr. Guan Wang
Dr. Dahong Yao
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- protein kinase
- inhibitors
- activators
- drug design
- drug discovery
- structure optimization
- drug repositioning
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
